Screener
Alamar Biosciences ALMR Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Alamar Biosciences in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213424
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest expense | (223) | (46) |
| Loss on remeasurement of convertible notes | (8,594) | — |
| Other (expense) income, net | (236) | 154 |
| Net loss before income tax | (20,861) | (7,659) |
| Provision for income taxes | 464 | — |
| Net loss | $(21,325) | $(7,659) |
| Net loss per share, basic and diluted | $(1.74) | $(0.68) |
| Weighted-average common shares outstanding, basic and diluted | 12,259,811 | 11,258,870 |
Item 1. Financial Statements
FAQ
- What is Alamar Biosciences's income tax?
- Alamar Biosciences (ALMR) reported income tax of $464K in Q1 2026.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Alamar Biosciences's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude